Elevated ALP in Children: Significance and Evaluation
Elevated alkaline phosphatase in children is most commonly physiologically normal due to bone growth, but when markedly elevated (>3-5 times upper limit), consider benign transient hyperphosphatasemia (BTH) in otherwise healthy children under 5 years, which requires only observation and repeat testing rather than extensive workup 1, 2.
Understanding the Physiology
ALP levels are physiologically higher in childhood due to active bone growth 1. This is critical context—what appears "elevated" by adult standards may be entirely normal for a growing child. The enzyme originates from liver (canalicular membrane), bone, and smaller amounts from intestines, kidneys, and white blood cells 1.
Key Clinical Decision Point: Is This BTH?
BTH Characteristics (Most Common Scenario)
BTH predominantly affects infants and toddlers aged 6 months to 6 years (median 13-24 months) 2, 3:
- ALP levels: Often 2,000-6,000 U/L, sometimes exceeding 10,000 U/L 2, 3, 4
- Magnitude: Average 7.4 times the upper limit of normal 3
- Clinical presentation: Otherwise healthy child, often detected during or after mild viral illness (gastroenteritis, respiratory infections) or incidentally 2, 3, 4
- Other labs: Normal liver enzymes, normal calcium, phosphate, PTH, vitamin D 4, 5
- Physical exam: Completely normal, no hepatosplenomegaly, no bone tenderness 4, 5
- Natural history: Spontaneous normalization in 44 days average (range 2-4 months) 3, 4
Diagnostic Algorithm for Isolated Elevated ALP
Step 1: Confirm hepatic vs. bone origin
- Measure GGT (gamma-glutamyl transpeptidase) 1
- GGT is not present in bone, only liver
- If GGT is normal → likely bone origin (physiologic growth or BTH)
- If GGT is elevated → hepatic cholestasis, proceed to imaging
Step 2: If GGT elevated (hepatic source)
- First-line imaging: Abdominal ultrasound 1
- Evaluate for biliary obstruction (choledocholithiasis most common), ductal dilatation, liver parenchymal disease
- Consider chronic cholestatic processes if isolated ALP persists: primary sclerosing cholangitis, primary biliary cholangitis, partial obstruction, drug-induced cholestasis 1
Step 3: If GGT normal and child appears healthy
- Check: CBC, comprehensive metabolic panel, calcium, phosphate, PTH, 25-OH vitamin D 4, 5
- If all normal → Diagnosis: BTH
- Management: Observation only, repeat ALP in 2-4 weeks 3, 5
- Expect 61% decrease by 2 weeks, normalization by 2-4 months 3
Common Pitfalls to Avoid
Over-investigation: The most important pitfall is subjecting healthy children to extensive hepatobiliary workup when BTH is the diagnosis 2, 6, 4, 5. This causes unnecessary parental anxiety and healthcare costs.
Missing pathologic causes: While BTH is common, don't assume it without checking GGT first. True cholestatic disease requires imaging 1.
Age-inappropriate reference ranges: Always use pediatric age-specific reference ranges—adult ranges will falsely suggest pathology 1.
Isoenzyme analysis: While both liver and bone isoenzymes are elevated in BTH 2, this test is not necessary for diagnosis and adds cost without changing management.
When BTH is NOT the Diagnosis
Pursue further workup if:
- Abnormal GGT → hepatobiliary imaging indicated
- Abnormal liver enzymes (AST, ALT, bilirubin) → hepatocellular disease
- Abnormal bone markers (calcium, phosphate, PTH) → metabolic bone disease
- Clinical symptoms: jaundice, hepatomegaly, bone pain, fractures
- Persistent elevation beyond 4 months without downward trend 3
- Age >6 years (BTH rare in older children) 2, 3
Pathologic Causes by Origin
Hepatic (with elevated GGT) 1:
- Extrahepatic obstruction: choledocholithiasis, strictures, malignancy
- Intrahepatic cholestasis: primary sclerosing cholangitis, drug-induced, infiltrative disease (sarcoidosis, metastases)
Bone (with normal GGT):
- Paget's disease, bony metastases, fractures (rare in children) 1
- Rickets, hyperparathyroidism (will have abnormal calcium/phosphate/PTH)